Concepedia

Shuhua Wang

SW

Statistics

Publications

2

Citations

28

H-Index

2

Active since

2024

Affiliations

Emory University(Current)

Shuhua Wang is an author at Emory University specializing in her2-positive breast cancer therapy, chemotherapy, and her2-positive metastatic disease.

Publications per year

2024–2025

2

Publications

2

VP1-2025: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial

Barbara Pistilli, Komal Jhaveri, S-A. Im et al. · Annals of Oncology · 2025 · 17 citations

Medicine, Oncology, Pharmacology +17

VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer

Tenzin Passang, Shuhua Wang, Hanwen Zhang et al. · Cancer Research · 2024 · 11 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–2 of 2